Form 4: Cognex EVP DiPalma's Stock Holdings Update
Insider Transaction Report
Cognex EVP Sheila DiPalma reported the vesting of restricted stock units and subsequent tax-related share dispositions, increasing her direct common stock ownership.
Summary
- Sheila Marie DiPalma, EVP, Employee Services at Cognex Corp (CGNX), reported changes in her beneficial ownership of company securities.
- On February 20, 2026, DiPalma acquired 3,803 shares of common stock through the vesting of restricted stock units (RSUs) at a price of $0.0.
- Concurrently, 1,117 shares were disposed of at $56.03 per share to cover tax withholding obligations related to the RSU vesting.
- On February 21, 2026, an additional 5,295 shares of common stock were acquired from RSU vesting at $0.0.
- 1,555 shares were disposed of at $56.03 per share on February 21, 2026, also for tax withholding purposes.
- Following these transactions, DiPalma's direct beneficial ownership of Cognex common stock increased to 15,013 shares.
- DiPalma continues to hold various non-qualified stock options and unvested restricted stock units.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a moderately positive event, as it represents the vesting of executive compensation, indicating continued alignment of executive interests with shareholder value, despite the routine tax-related sales.
Positives
- Vesting of 9,098 restricted stock units (3,803 + 5,295) indicates compensation realization and continued executive equity ownership.
- Net increase in direct common stock beneficial ownership from an estimated 9,704 shares to 15,013 shares after all reported transactions.
Negatives
- Disposition of 2,672 shares (1,117 + 1,555) to cover tax obligations, which reduces the total shares retained from vesting.
Future Outlook
NA
Industry Context
StockSavvy.ai notes that Form 4 filings are routine disclosures of insider transactions and typically do not provide direct insights into broader industry trends or competitive landscape. This filing reflects standard executive compensation practices within the technology sector, where equity awards like RSUs and stock options are common.
Stakeholder Impact
- Shareholders: Minor impact from routine executive compensation vesting and tax-related sales. Indicates continued executive equity ownership.
- Employees: Reflects standard executive compensation practices, which may influence broader compensation strategies.
Next Steps
- Future vesting of remaining Restricted Stock Units granted on February 20, 2024 (20%, 30%, 50% on 1st, 2nd, 3rd anniversaries).
- Future vesting of remaining Restricted Stock Units granted on February 21, 2023 (20%, 30%, 50% on 1st, 2nd, 3rd anniversaries).
- Future vesting of Restricted Stock Units granted on February 18, 2026, and February 17, 2027.
- Potential exercise of various Non-Qualified Stock Options prior to their expiration dates.
Key Dates
| Date | Description |
|---|---|
| 02/21/2018 | Grant date for Non-Qualified Stock Option with exercise price $38.39, expiring 02/21/2027. |
| 11/01/2018 | Grant date for Non-Qualified Stock Option with exercise price $62.48, expiring 11/01/2027. |
| 02/19/2020 | Grant date for Non-Qualified Stock Option with exercise price $51.49, expiring 02/19/2029. |
| 02/18/2021 | Grant date for Non-Qualified Stock Option with exercise price $50.94, expiring 02/18/2030. |
| 02/22/2023 | Grant date for Non-Qualified Stock Option with exercise price $64.43, expiring 02/22/2032. |
| 02/21/2023 | Grant date for Restricted Stock Units, vesting approximately 20%, 30%, and 50% on the first, second, and third anniversaries, respectively. |
| 02/21/2024 | First anniversary vesting for RSUs granted 02/21/2023; also grant date for Non-Qualified Stock Option with exercise price $47.21, expiring 02/21/2033. |
| 02/20/2024 | Grant date for Restricted Stock Units, vesting approximately 20%, 30%, and 50% on the first, second, and third anniversaries, respectively. |
| 02/20/2025 | First anniversary vesting for RSUs granted 02/20/2024; also grant date for Non-Qualified Stock Option with exercise price $39.44, expiring 02/20/2034. |
| 10/30/2025 | Grant date for Non-Qualified Stock Option with exercise price $65.90, expiring 10/30/2030. |
| 02/18/2026 | Grant date for Restricted Stock Units, expiring 02/18/2028; also grant date for Non-Qualified Stock Option with exercise price $33.04, expiring 02/18/2035. |
| 02/20/2026 | Vesting of 3,803 Restricted Stock Units and disposition of 1,117 shares for tax withholding. |
| 02/21/2026 | Vesting of 5,295 Restricted Stock Units and disposition of 1,555 shares for tax withholding. |
| 02/24/2026 | Signature date of the reporting person. |
| 02/17/2027 | Grant date for Restricted Stock Units, expiring 02/17/2029; also grant date for Non-Qualified Stock Option with exercise price $57.09, expiring 02/17/2036. |
Keywords
Cognex, CGNX, Sheila DiPalma, Insider Trading, Form 4, Restricted Stock Units, Stock Options, Executive Compensation, Share Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.